Physician Focused Intervention to Improve Adherence With HIV Antiretrovirals

HIV Infections Clinical Trial

— MAP  

Official title:

Physician Focused Intervention to Improve Adherence With HIV Antiretrovirals

Clinical Trial Details — Status: Completed

Administrative data

• NCT number: NCT00870792
• Other study ID #: ibwadhrct88$
• Status: Completed
• Phase: N/A
• First received: March 26, 2009
• Last updated: January 10, 2017
• Start date: November 2002
• Est. completion date: February 2005

Study information

• Verified date: March 2009
• Source: National Institute on Drug Abuse (NIDA)
• Contact: n/a
• Is FDA regulated: No
• Health authority: United States: Federal Government
• Study type: Interventional

Clinical Trial Summary

We hypothesized that providing physicians treating with HIV disease, at the time of a routine outpatient visit, with a detailed report describing patients' adherence with HIV antiretroviral medications, would improve the quality of the physician-patient interaction, and also patients' subsequent adherence.

Recruitment information / eligibility

• Status: Completed
• Enrollment: 156
• Est. completion date: February 2005
• Est. primary completion date: January 2005
• Accepts healthy volunteers: No
• Gender: All
• Age group: 18 Years and older

Eligibility

Inclusion Criteria:

• on ART

• willing to use MEMS cap

• speaks and reads English

• detectable viral loads

Exclusion Criteria:

• uses a pill box

Study Design

Allocation: Randomized, Endpoint Classification: Efficacy Study, Intervention Model: Crossover Assignment, Masking: Open Label, Primary Purpose: Health Services Research

Related Conditions & MeSH terms

• Acquired Immunodeficiency Syndrome
• Communicable Diseases
• HIV Infection
• HIV Infections
• Infection

Intervention

Behavioral:
• Adherence report
During the intervention phase, the data collected at the study visit were summarized in a 3-page report that was given to the provider before each intervention visit. The report included data on self-reported adherence, MEMS adherence, reminder use, beliefs about ART, reasons for missed doses, alcohol and drug use, and depression.

Locations

Country	Name	City	State
United States	Tufts Medical Center	Boston	Massachusetts

Sponsors (1)

Lead Sponsor	Collaborator
National Institute on Drug Abuse (NIDA)

Country where clinical trial is conducted

United States, 

References & Publications (2)

Lu M, Safren SA, Skolnik PR, Rogers WH, Coady W, Hardy H, Wilson IB. Optimal recall period and response task for self-reported HIV medication adherence. AIDS Behav. 2008 Jan;12(1):86-94. — View Citation

Vranceanu AM, Safren S, Cowan J, Ring D. The development of the negative pain thoughts questionnaire. Pain Pract. 2008 Sep-Oct;8(5):337-41. doi: 10.1111/j.1533-2500.2008.00213.x. — View Citation

Outcome

Type	Measure	Description	Time frame	Safety issue
Primary	Antiretroviral medication adherence as assessed by electronic pill cap monitoring.		6 months	No
Secondary	Self-reported medication adherence		6 months	No